{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:37:07Z","timestamp":1790487427543,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Maruho Co., LTD"}],"content-domain":{"domain":["clinicalkey.jp","jdsjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jdermsci.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T13:59:43Z","timestamp":1535119183000},"page":"117-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The vitamin D3 analog, maxacalcitol, reduces psoriasiform skin inflammation by inducing regulatory T cells and downregulating IL-23 and IL-17 production"],"prefix":"10.1016","volume":"92","author":[{"given":"Carren Sy.","family":"Hau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Takeoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kadono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2018.08.007_bib0005","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0010","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.coph.2010.04.001","article-title":"Vitamin D: modulator of the immune system","volume":"10","author":"Baeke","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0015","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1995.tb00710.x","article-title":"Biological activity of vitamin D analogues in the skin with special reference to antipsoriatic mechanisms","volume":"132","author":"van de Kerkhof","year":"1995","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4049\/jimmunol.1000695","article-title":"The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation","volume":"186","author":"Baeke","year":"2011","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.jdermsci.2018.08.007_bib0025","article-title":"1,25-Dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type 1 diabetes patients","author":"van Belle","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0030","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.4049\/jimmunol.0801543","article-title":"Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response","volume":"182","author":"Tang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2133.2012.10917.x","article-title":"Topical vitamin D\u2083 analogues induce thymic stromal lymphopoietin and cathelicidin in psoriatic skin lesions","volume":"167","author":"Sato-Deguchi","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/apm.12378","article-title":"1,25-dihydroxyvitamin D3 regulates the development of chronic colitis by modulating both T helper (Th)1 and Th17 activation","volume":"123","author":"Zhang","year":"2015","journal-title":"APMIS"},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/1744666X.3.4.477","article-title":"Vitamin D receptor agonists as anti-inflammatory agents","volume":"3","author":"Adorini","year":"2007","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0050","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/jid.2011.486","article-title":"Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 \"alarmins\" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis","volume":"132","author":"Hegyi","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.smim.2003.12.008","article-title":"Pharmacological induction of tolerogenic dendritic cells and regulatory T cells","volume":"16","author":"Adorini","year":"2004","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0060","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s004030050444","article-title":"The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes","volume":"291","author":"Komine","year":"1999","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0923-1811(02)00136-6","article-title":"Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation","volume":"31","author":"Takahashi","year":"2003","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1046\/j.1365-2133.1999.02975.x","article-title":"Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator","volume":"141","author":"Barker","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/09546630305545","article-title":"Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy","volume":"14","author":"Camarasa","year":"2003","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0080","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.intimp.2014.12.032","article-title":"Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation","volume":"24","author":"Sun","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0090","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1038\/ncomms8687","article-title":"Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from \u03b3\u03b4-T cells","volume":"6","author":"Shibata","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.178.1.145","article-title":"1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells","volume":"178","author":"Penna","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0100","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0105","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"Penna","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0110","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/bbrc.2000.2490","article-title":"Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs","volume":"270","author":"Griffin","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0115","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/diabetes.51.7.2119","article-title":"Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3)","volume":"51","author":"van Halteren","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/imm.12518","article-title":"Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin","volume":"146","author":"Ali","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0125","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jaci.2011.01.068","article-title":"Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells","volume":"127","author":"van der Aar","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0130","first-page":"1458","article-title":"1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation","volume":"3","author":"Adorini","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.humimm.2009.01.016","article-title":"Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists","volume":"70","author":"Adorini","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0140","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.4049\/jimmunol.0804064","article-title":"Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol","volume":"182","author":"Ghoreishi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1172\/JCI21759","article-title":"Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients","volume":"116","author":"Xystrakis","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0150","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.176.4.2635","article-title":"Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10","volume":"176","author":"Ghoreishi","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0190-9622(98)70323-8","article-title":"Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement","volume":"39","author":"Lebwohl","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2017.01.003","article-title":"Skin-derived TSLP systemically expands regulatory T cells","volume":"79","author":"Leichner","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jdermsci.2018.08.007_bib0165","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.4049\/jimmunol.179.9.6273","article-title":"Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes","volume":"179","author":"Gorman","year":"2007","journal-title":"J. Immunol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118303098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118303098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T17:26:01Z","timestamp":1544117161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181118303098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0923181118303098"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.08.007","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The vitamin D3 analog, maxacalcitol, reduces psoriasiform skin inflammation by inducing regulatory T cells and downregulating IL-23 and IL-17 production","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}